Wednesday, 7 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Gujarat Inject (Kerala) Ltd

BSE: 524238 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹9.50
Market cap: ₹139.2 Cr
Revenue (annual): ₹36.32 Cr
Net profit (annual): ₹1.81 Cr
P/E (TTM): 46.5×Sector 47.4×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 5 Annual General Meeting 4 Financial Results 3 Other Announcement 2 New Order Win 2 Capital Structure Change 2 Stock Split 1 Results Update 1 Partnership 1 Legal & Regulatory 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

15 Jul 2026 10:02 IST BSE

Financial Results

Gujarat Inject (Kerala) Q1 FY27 Results: Net Profit ₹1.3 Cr, Up 1200.0% YoY

Gujarat Inject (Kerala) Ltd reported revenue from operations of ₹12.5 Cr (+420.8% YoY) and net profit of ₹1.3 Cr (+1200.0% YoY) for Q1 FY27.

Key figure: Net profit ₹1.3 Cr · +1200.0% YoY

Open full results → Read the filing ↗

20 May 2026 19:00 IST BSE

Financial Results

Gujarat Inject (Kerala) Q4 FY26 Results: Net Profit ₹1.6 Cr, Up 1500.0% YoY

Gujarat Inject (Kerala) Ltd reported revenue from operations of ₹30.7 Cr (+631.0% YoY) and net profit of ₹1.6 Cr (+1500.0% YoY) for Q4 FY26.

Key figure: Net profit ₹1.6 Cr · +1500.0% YoY

Open full results → Read the filing ↗

20 May 2026 18:59 IST BSE

Financial Results

Gujarat Inject (Kerala) Financial Results

Gujarat Inject Kerala Ltd reported a total income of ₹36.52 Crore for FY26. Net profit rose significantly to ₹1.81 Crore from ₹1.02 Crore YoY.

Value: ₹36.52 Cr

Read the filing ↗